Clinical Laserthermia Systems AB (publ)
STO: CLS-B.ST0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Stockholm Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Dan Johansson Mogren
- Employees
- 17
- Headquarters
- Lund, Sweden
- IPO year
- 2009
- Market cap
- SEK 90.9M
- Website
- https://www.clinicallaser.se
Loading CLS-B…
Loading profile data…Frequently asked questions about CLS-B
What does Clinical Laserthermia Systems AB (publ) (CLS-B.ST) do?
Clinical Laserthermia Systems AB (publ) develops treatment tools for diseased tissue under the TRANBERG brand in Sweden. The company offers TRANBERG, a thermal therapy system designed to deliver laser energy to heat the target tissue. It also provides mobile laser unit, a controlling component with a wavelength of 1064 nanometers provides multip...
Where does CLS-B.ST trade?
Clinical Laserthermia Systems AB (publ) (CLS-B.ST) trades on the Stockholm Stock Exchange.
What sector is CLS-B.ST in?
Clinical Laserthermia Systems AB (publ) (CLS-B.ST) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of Clinical Laserthermia Systems AB (publ)?
Dan Johansson Mogren is the chief executive officer of Clinical Laserthermia Systems AB (publ) (CLS-B.ST).
Where is Clinical Laserthermia Systems AB (publ) headquartered?
Clinical Laserthermia Systems AB (publ) is headquartered in Sweden.
Does CLS-B.ST pay a dividend?
Clinical Laserthermia Systems AB (publ) (CLS-B.ST) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did CLS-B.ST go public?
Clinical Laserthermia Systems AB (publ) (CLS-B.ST) completed its initial public offering in 2009.